HEALWELL AI Boosts Research with BioPharma Acquisition

MCI Onehealth Technologies, Inc. Class A (TSE:AIDX) has released an update.

HEALWELL AI is set to enhance its clinical research capabilities through the strategic acquisition of BioPharma Services Inc., a prominent Canadian Contract Research Organization (CRO) specializing in bioequivalence and early-stage clinical trials. By integrating BioPharma’s expertise with its own AI technologies and vast patient databases, HEALWELL aims to accelerate and improve patient-centered clinical research. The deal includes an initial $11.9 million in cash and shares with potential additional performance-based payments, bolstering HEALWELL’s projected annual revenue to over $65 million.

For further insights into TSE:AIDX stock, check out TipRanks’ Stock Analysis page.